Weakened profitability is ‘labor pain to become global pharmaceuticals’
Some of the top pharmaceutical companies have been weakened in profitability due to active expansion of investments in R&D.
According to the pharmaceutical industry, triggered by the Hanmi Pharm’s successful cases, they have shown tendency to enlarge R&D investments.
In the process, some of pha...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
